Related references
Note: Only part of the references are listed.An Overview on Chemical Aspects and Potential Health Benefits of Limonoids and Their Derivatives
Rosa Tundis et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2014)
Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis
Jason Boyang Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Monoamine oxidases as sources of oxidants in the heart
Nina Kaludercic et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Selective MAO-B inhibitors: a lesson from natural products
Simone Carradori et al.
MOLECULAR DIVERSITY (2014)
A Novel Monoterpene-Stilbene Adduct with a 4,4-Dimethyl-2,3-diphenylchromane Skeleton from Artocarpus xanthocarpus
Horng-Huey Ko et al.
CHEMISTRY & BIODIVERSITY (2013)
Inhibitor Design for Monoamine Oxidases
Rona R. Ramsay
CURRENT PHARMACEUTICAL DESIGN (2013)
Aphanamgrandiol A, a new triterpenoid with a unique carbon skeleton from Aphanamixis grandifolia
Qi Zeng et al.
FITOTERAPIA (2013)
Chemistry and Biology of Indoles and Indazoles: A Mini-Review
Nasir Shafakat Ali et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
Fluevirosines A-C: A Biogenesis Inspired Example in the Discovery of New Bioactive Scaffolds from Flueggea virosa
Hue Zhang et al.
ORGANIC LETTERS (2013)
Two New Highly Oxygenated and Rearranged Limonoids from Phyllanthus cochinchinensis
Jian-Qiang Zhao et al.
ORGANIC LETTERS (2013)
Antiviral Spirooliganones A and B with Unprecedented Skeletons from the Roots of Illicium oligandrum
Shuang-Gang Ma et al.
ORGANIC LETTERS (2013)
Aspeverin, a New Alkaloid from an Algicolous Strain of Aspergillus versicolor
Nai-Yun Ji et al.
ORGANIC LETTERS (2013)
Opportunities for reversible inhibitors of monoamine oxidase-A (RIMAs) in the treatment of depression
Christopher T. Lum et al.
CNS SPECTRUMS (2012)
Herbal Natural Products As a Source of Monoamine Oxidase Inhibitors: A Review
Dolores Vina et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Discovery and Optimization of Pyrazoline Derivatives As Promising Monoamine Oxidase Inhibitors
Daniela Secci et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2012)
Triterpenes possessing an unprecedented skeleton isolated from hydrolyzate of total saponins from Gynostemma pentaphyllum
Ning Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives
Lesetja J. Legoabe et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential
Simone Carradori et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Two New-Skeleton Compounds from Sarcandra glabra
Xiong Li et al.
HELVETICA CHIMICA ACTA (2012)
Neonectrolide A, a New Oxaphenalenone Spiroketal from the Fungus Neonectria sp.
Jinwei Ren et al.
ORGANIC LETTERS (2012)
Lycojaponicumins A-C, Three Alkaloids with an Unprecedented Skeleton from Lycopodium japonicum
Xiao-Jing Wang et al.
ORGANIC LETTERS (2012)
Eryngiolide A, a Cytotoxic Macrocyclic Diterpenoid with an Unusual Cyclododecane Core Skeleton Produced by the Edible Mushroom Pleurotus eryngii
Shao-juan Wang et al.
ORGANIC LETTERS (2012)
Chukrasones A and B: Potential Kv1.2 Potassium Channel Blockers with New Skeletons from Chukrasia tabularis
Hong-Bing Liu et al.
ORGANIC LETTERS (2012)
Aphanamixoid A, a Potent Defensive Limonoid, with a New Carbon Skeleton from Aphanamixis polystachya
Jie-Yun Cai et al.
ORGANIC LETTERS (2012)
Kadcoccitones A and B, Two New 6/6/5/5-Fused Tetracyclic Triterpenoids from Kadsura coccinea
Cheng-Qin Liang et al.
ORGANIC LETTERS (2012)
Incarviatone A, a structurally unique natural product hybrid with a new carbon skeleton from Incarvillea delavayi, and its absolute configuration via calculated electronic circular dichroic spectra
Yun-Heng Shen et al.
RSC ADVANCES (2012)
From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors
Spyros N. Deftereos et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2012)
The State of the Art of Pyrazole Derivatives as Monoamine Oxidase Inhibitors and Antidepressant/Anticonvulsant Agents
D. Secci et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives
Daniela Secci et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Dietary inhibitors of monoamine oxidase A
Sarah E. Dixon Clarke et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Insomnia, platelet serotonin and platelet monoamine oxidase in chronic alcoholism
Korona Nenadic Sviglin et al.
NEUROSCIENCE LETTERS (2011)
Site-Activated Chelators Targeting Acetylcholinesterase and Monoamine Oxidase for Alzheimer's Therapy
Hailin Zheng et al.
ACS CHEMICAL BIOLOGY (2010)
Focusing on new monoamine oxidase inhibitors
Adriana Bolasco et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Synthesis and Anti-Helicobacter pylori Activity of 4-(Coumarin-3-yl)thiazol-2-ylhydrazone Derivatives
Franco Chimenti et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2010)
The Novel Multifunctional, Iron-Chelating Drugs M30 and HLA20 Protect Pancreatic β-Cell Lines from Oxidative Stress Damage
Danit Mechlovich et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium
S. C. Stanford et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2010)
Synthesis and Biological Evaluation of Novel Conjugated Coumarin-Thiazole Systems
Franco Chimenti et al.
JOURNAL OF HETEROCYCLIC CHEMISTRY (2009)
Synthesis, Molecular Modeling, and Selective Inhibitory Activity against Human Monoamine Oxidases of 3-Carboxamido-7-Substituted Coumarins
Franco Chimenti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Altered Platelet Monoamine Oxidase-B Activity in Idiopathic Parkinson's Disease
Maroof Husain et al.
NEUROCHEMICAL RESEARCH (2009)
Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B
David M. Gooden et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
The selegiline transdermal system in major depressive disorder: A systematic review of safety and tolerability
Donald S. Robinson et al.
JOURNAL OF AFFECTIVE DISORDERS (2008)
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
William J. Burke et al.
ACTA NEUROPATHOLOGICA (2008)
Monoamine oxidase-B inhibition in the treatment of Parkinson's disease
Hubert H. Fernandez et al.
PHARMACOTHERAPY (2007)
Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction
R. R. Ramsay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Platelet monoamine oxidase activity in obsessive-compulsive disorder
Manuel Arrojo et al.
EUROPEAN PSYCHIATRY (2007)
Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: The role of aldehyde dehydrogenase
Satori A. Marchitti et al.
PHARMACOLOGICAL REVIEWS (2007)
A bioluminescent assay for monoamine oxidase activity
Michael P. Valley et al.
ANALYTICAL BIOCHEMISTRY (2006)
Symptom relief in Parkinson disease by safinamide - Biochemical and clinical evidence of efficacy beyond MAO-B inhibition
F. Stocchi et al.
NEUROLOGY (2006)
Methylene blue implicated in potentially fatal serotonin toxicity
P. K. Gillman
ANAESTHESIA (2006)
Synthesis, molecular modeling studies, and selective inhibitory activity against monoamine oxidase of N,N′-bis[2-oxo-2H-benzopyran]-3-carboxamides
Franco Chimenti et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
The therapeutic potential of monoamine oxidase inhibitors
MBH Youdim et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Recent development of monoamine oxidase inhibitors
A Bolasco et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2005)
Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives
S Mandel et al.
BRAIN RESEARCH REVIEWS (2005)
Structure and mechanism of monoamine oxidase
DE Edmondson et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Moclobemide: Therapeutic use and clinical studies
U Bonnet
CNS DRUG REVIEWS (2003)
Natural product guided compound library development
R Breinbauer et al.
CURRENT MEDICINAL CHEMISTRY (2002)
Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation
I Berlin et al.
ADDICTION (2002)
Neuroprotection by propargylamines in Parkinson's disease - Suppression of apoptosis and induction of prosurvival genes
W Maruyama et al.
NEUROTOXICOLOGY AND TERATOLOGY (2002)
Novel aspects of dopamine oxidative metabolism (confounding outcomes take place of certainties)
M Gesi et al.
PHARMACOLOGY & TOXICOLOGY (2001)
Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat
MC Carrillo et al.
LIFE SCIENCES (2000)
Share Paper
